Novo Nordisk to lower insulin prices by 75%
Novo Nordisk announced plans Tuesday to lower the cost of several of its insulin products by up to 75% for people living with Type 1 and Type 2 diabetes.
CDC investigating after more than 300 sickened aboard Princess Cruises ship
The Ruby Princess, of the Princess Cruises lines, had more than 300 passengers and crew fall ill with symptoms that included vomiting and diarrhea during the Caribbean trip.
FDA to decide on full approval of Alzheimer's treatment Leqembi in early July
The FDA will decide on July 6 whether to grant full approval to the new Alzheimer's treatment Leqembi, Japanese drugmaker Eisai and its U.S. partner Biogen said.
Altria buying vape maker NJOY for $2.75B
Altria will buy vape-maker NJOY and absorb the company’s NJOY ACE production as the only e-vapor product with market authorizations from the U.S. Food and Drug Administration (FDA).
Russell Stover recalls Sugar Free Peanut Butter Cups after learning of potential for undeclared pecans
Russell Stover recalled its Sugar Free Peanut Butter Cups after learning packages might contain Sugar Free Pecan Delights -- a life-threatening error for those with a pecan allergy.
TikTok sets default screen time limit for teens
TikTok on Wednesday announced that it is setting a new default time limit for users under 18 years old amid growing scrutiny over the popular social media app.
Apple has no-prick glucose monitor in the works
Apple has reportedly been developing a no-prick glucose monitor, according to a Wednesday report from Bloomberg that cites people familiar with the matter.
More than 60 companies tried a four-day work week and results show why 92% are keeping it
More than 60 British companies tried a four-day work week over a six month period and the results show why 92% are going to keep that schedule moving forward.
Opioid antidote Narcan should be available over the counter, FDA panel says
A panel urged the FDA to give final approval to a plan that would make Narcan, the nasal version of the overdose-reversal drug naloxone, available over the counter.
GoodRx to pay $1.5 million fine as part of FTC settlement
GoodRx will have to pay a $1.5 million fine as part of a proposed settlement with the Federal Trade Commission if it gets approved by a federal court.
FDA calls on Congress to create new regulations for hemp-derived CBD products
The FDA said Thursday that there are still too many unknowns about the burgeoning market for CBD products to regulate them as either food or supplements.
FDA rejects Lilly’s alzheimer’s drug candidate, seeks more data
Lilly said it would work with the FDA to evaluate the fastest pathway to get its Alzheimer’s drug to market after what it believes was a successful trial.
Amazon hit with OSHA citations at 3 facilities due to 'ergonomic hazards' for workers
OSHA has issued citations against three Amazon facilities for conditions they say exposed workers to risk of lower back and other musculoskeletal injuries.
CVS nurse fired after refusing to prescribe birth control over religious beliefs sues pharmacy
A former nurse practitioner for CVS claimed she had been discriminated against for her religious beliefs in a lawsuit filed against the company Wednesday after she had been fired for refusing to prescribe birth control.
House Republicans call on Biden not to ban gas stoves: ''Nanny state' at its worst'
House Republicans are demanding that the Biden administration cease any effort to ban gas stoves in American homes, after reports floated the idea earlier this week.
Recalled Fisher-Price sleeper now linked to roughly 100 deaths, CPSC says
Fisher-Price and the CPSC “reannounced” a recall of Rock ‘n Play Sleepers on Monday, saying that eight fatalities have occurred after the initial recall announcement.
Rite Aid announces Heyward Donigan exit, appointment of interim CEO
Rite Aid experienced a leadership shakeup as the pharmacy change announce CEO Heyward Donigan's exit and the appointment of an interim chief executive.
FDA approves Biogen, Eisai Alzheimer’s drug
An Alzheimer’s drug from Biogen and Eisai has received accelerated approval from the Food and Drug Administration, the companies and agency announced Friday.
Beyond Dry January: The rise of non-alcoholic drinks in the adult beverage market
Ditching alcohol in the first month of the year has become a trend, but the beverage industry sees opportunity in non-alcoholic drinks beyond just Dry January.
FDA considers regulating cannabis compound CBD in foods, supplements over safety concerns
The FDA is weighing whether CBD products can be regulated under rules covering food and dietary supplements or if a new framework is needed.